Cite
HARVARD Citation
Klaska, I. et al. (2022). Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization. Experimental eye research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klaska, I. et al. (2022). Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization. Experimental eye research. p. . [Online].